News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

01

2025

-

12

Linuo Pharmaceutical held a special work meeting for the marketing division of its healthcare business, adopting multiple measures to sprint toward the annual targets!

Classification:

行业新闻

Corporate News


On November 5, the marketing special working conference of the pharmaceutical business unit of Linuo Pharmaceutical was held in Jinan. The meeting focused on “ Secure victory in the fourth quarter and set sail for a new era. With the theme of “ ”, Chairman Li Hongfu, all vice presidents, regional marketing directors, and heads of relevant departments attended the meeting together. Hold in-depth discussions around key issues such as the fourth-quarter sales targets and channel expansion. To rally consensus and clarify the path for fully sprinting toward the annual goals.

At the start of the meeting, marketing experts from various regions will first... Visited the injectable products project. By visiting core areas such as the Intelligent Wisdom Laboratory and the workshop of Digital Intelligence Plant No. 1, attendees personally experienced the automated operation scenarios of the freeze-dried powder injection production line and the BFS sterile preparation production line, witnessing... An intelligent manufacturing system covering the entire process from R&D and production to quality control. Subsequently, the meeting kicked off with a program featuring “singing the Lino Song, reciting the Lino Ode, and reading the corporate culture.” Strengthen team cohesion and strategic consensus through cultural immersion.

Chairman Li Hongfu delivered a keynote speech, emphasizing that the fourth quarter is a critical phase for achieving the year’s goals, and he called for... All marketing personnel are closely focused on targets and strengthening execution. Collaborate effectively in areas such as continued bidding for centralized procurement, deepening channel development, and risk management to ensure the achievement of... Performance Breakthrough and Management Improvement Win-win. The heads of each region took the stage one by one to deliver reports, going into great detail. Analyze market dynamics Face the issues head-on and anchor on a clear strategy. Relevant departments should communicate and collaborate on matters such as market access, brand building, and human resource support to further strengthen [something—likely a specific initiative or capability]. Front-, Middle-, and Back-Office Coordination Mechanism

Diligent cultivation and meticulous work will ensure victory today; strategic, long-term planning will secure success in the future. Chairman Li Hongfu fully affirmed the Medical Business Division’s efforts and achievements in the first three quarters, while also pointing out that the fourth quarter presents both daunting challenges and promising opportunities. He called on all staff to embrace a sense of mission—“setting sail for a new era”—and to rise to the occasion. Focus on targets, optimize strategies, and ensure accountability. Together, we will drive NovoPharm to achieve higher-quality development in the pharmaceutical industry’s new cycle.

This meeting systematically reviewed the key links in the marketing system and strengthened... Organizational Coordination and Goal Consensus This has injected firm confidence and strong momentum into Linuo Pharmaceutical’s all-out efforts to make a strong finish in the fourth quarter and win the year-end battle.

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

2026-05-13

On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

2026-05-07

On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.

Great news! First prize!

Great news! First prize!

2026-05-07

Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.